New Market Research
New market research information from the USA shows projected growth of the market reaching a global value of $475 million by 2024.
The growth is being driven by a series of key factors:
- Availability of non-invasive procedures for treating varicose veins i.e. EVLA or injections
- Demand for less-invasive procedures
- Increase in vascular diseases, linked to the ageing population and rise in obesity
- Ageing populations
- Growth in healthcare expenditure
The report summary says:
“The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure.”
The published report summary says:
“In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures.”
Procedures such as sclerotherapy for thread veins and foam sclerotherapy for varicose veins are based on injecting specially formulated chemicals into the troublesome veins. The chemicals work to destroy the vein so that blood flows elsewhere.
Laser Varicose Vein Treatment
General marketplace indications are that new laser vein treatments will be seen as highly appealing. They are non-invasive procedures, but offer excellent outcomes with minimal discomfort and recovery implications.
The gold-standard treatment is EVLA – endovenous laser ablation.
Private treatment is available at clinics such as Cosmedics’ London Vein Treatment Centre, a company who has seen dramatic increase in interest for the advanced varicose vein treatment procedure.
Varicose Vein Treatment
Cosmedics Skin Clinics offer private varicose vein treatment and see many patients who have been refused treatment on the NHS.
Their London Vein Treatment Centre offers EVLA (endovenous laser ablation) laser varicose vein removal with a vascular surgeon with prices starting at £1,650 per leg (1 vein).
For more information or to book a consultation, please complete the form on this web page or call 020 7386 0464.